Oss, Netherlands

Wouter Wiedenhof



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wouter Wiedenhof: Innovator in Pharmaceutical Chemistry

Introduction

Wouter Wiedenhof is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various medical conditions. His innovative work has led to the filing of a patent that addresses critical health issues.

Latest Patents

Wouter Wiedenhof holds a patent for N-piperidin-4-yl derivatives. This invention relates to a N-piperidin-4-yl derivative having the general Formula I or a pharmaceutically acceptable salt thereof. The patent encompasses pharmaceutical compositions that include these derivatives and their use in the treatment and prevention of endometriosis, pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids or other menstrual-related disorders.

Career Highlights

Wouter Wiedenhof is associated with Merck Sharp & Dohme B.V., a leading global healthcare company. His role in the company has allowed him to contribute to the advancement of pharmaceutical research and development. His work is characterized by a commitment to improving health outcomes through innovative solutions.

Collaborations

Wouter has collaborated with esteemed colleagues such as Ines Huisman and Marcelis Van Der Stelt. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Wouter Wiedenhof's contributions to pharmaceutical chemistry through his patent on N-piperidin-4-yl derivatives highlight his role as an innovator in the field. His work continues to pave the way for advancements in treatments for significant health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…